Categories
Health

Pembrolizumab Benefits CCGC Patients

Source link : https://www.newshealth.biz/health-news/pembrolizumab-benefits-ccgc-patients/

TOPLINE: Pembrolizumab provided clinical benefit in previously treated advanced clear cell gynaecological cancer (CCGC). METHODOLOGY: A single-arm multicentre phase 2 trial conducted at five UK centres enrolled 48 patients with advanced CCGC between March 2019 and October 2021, with data collected until July 2024. Participants (median age, 58.5 years) received intravenous pembrolizumab (200 mg) every […]

Author : News Health

Publish date : 2025-02-18 12:00:00

Copyright for syndicated content belongs to the linked Source.

.. . . . . . . . . . . . . . . . . . . . . . . . . %%%. . . * . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ $ - - - - - - - - - - - - - - - - - - - - . . . . .